CD95-mediated murine hepatic apoptosis requires an intact glutathione status

Hepatology

Volumn 30, Issue 1, 1999, Pages 177-185

  Hentze, Hannes ^a   Künstle, Gerald ^a   Volbracht, Christiane ^a   Ertel, Wolfgang ^b   Wendel, Albrecht ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; BUTYLCRESOL; CASPASE; CATALASE; CYTOKINE RECEPTOR; DNA FRAGMENT; FAS ANTIGEN; GLUTATHIONE ETHYL ESTER; PHORONE;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DEATH; ENZYME ACTIVATION; ENZYME INHIBITION; HISTOPATHOLOGY; LIVER CELL; LIVER FAILURE; LIVER HISTOLOGY; LIVER INJURY; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; WESTERN BLOTTING;

ACETYLCYSTEINE; AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANTIGENS, CD95; ANTIOXIDANTS; APOPTOSIS; BUTYLATED HYDROXYTOLUENE; CASPASE 3; CASPASES; CATALASE; CYSTEINE PROTEINASE INHIBITORS; DNA FRAGMENTATION; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE TRANSFERASE; HUMANS; KETONES; LIVER; MALE; MICE; MICE, INBRED BALB C; VITAMIN E;

EID: 0032999223     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300111     Document Type: Article

References (27)

1. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME. Apoptosis signaling by death receptors. Eur J Biochem 1998;254:439-459.
2. Nagata S. Apoptosis by death factor. Cell 1997;88:355-365.
3. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. Exp Med 1995;182:1223-1230.
4. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugal T, Kitamura Y, Itoh N, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993;364:806-809.
5. Leist M, Gantner F, Künstle G, Bohlinger I, Tiegs G, Bluethmann H, Wendel A. The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure. Mol Med 1996;2:109-124.
6. Leist M, Gantner F, Künstle G, Wendel A. Cytokine-mediated hepatic apoptosis. Rev Physiol Biochem Pharmacol 1998;133:109-155.
7. Galle PR, Krammer PH. CD95-induced apoptosis in human liver disease. Semin Liver Dis 1998;18:141-151.
8. Feldmann G. Liver apoptosis. J Hepatol 1997;26:1-11.
9. Strand S, Galle PR. Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implications. Mol Med Today 1998;4:63-68.
10. Natoli G, Ianni A, Costanzo A, De Petrillo G, Ilari I, Chirillo P, Balsano C, et al. Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene 1995;11:1157-1164.
11. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 1997;16:2794-2804.
12. Zhivotovsky B, Burgess DH, Vanags DM, Orrenius S. Involvement of cellular proteolytic machinery in apoptosis. Biochem Biophys Res Commun 1997;230:481-488.
13. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-1316.
14. Hirata H, Takahashi A, Kobayashi S, Yonehara S, Sawai H, Okazaki T, Yamamoto K, et al. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med 1998;187:587-600.
15. Widmann C, Gibson S, Johnson GL. Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J Biol Chem 1998;73:7141-7147.
16. Nobel CSI, Kimland M, Nicholson DW, Orrenius S, Slater AFG. Disulfiram is a potent inhibitor of proteases of the caspase family. Chem Res Toxicol 1997;10:1319-1324.
17. Li J, Billiar TR, Talanian RV, Kim YM. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun 1997;240:419-424.
18. Jones RA, Johnson VL, Buck NR, Dobrota M, Hinton RH, Chow SC, Kass GEN. Fas-mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases. HEPATOLOGY 1998;27:1632-1642.
19. Jaeschke H, Fisher MA, Lawson JA, Simmons CA, Farhood A, Jones DA. Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. J Immunol 1998;160:3480-3486.
20. Rodriguez I, Matsuura K, Ody C, Nagata S, Vassalli P. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J Exp Med 1996;184:2067-2072.
21. Rouquet N, Pages JC, Molina T, Briand P, Joulin V. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis. Curr Biol 1996;6:1192-1195.
22. Künstle G, Leist M, Uhlig S, Revesz L, Feifel R, Mackenzie A, Wendel A. ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha. Immunol Lett 1997;55:5-10.
23. Wendel A, Tiegs G, Werner C. Manipulation of liver glutathione status - a double-edged sword. In: Vina J, ed. Glutathione: Metabolism and Physiological Functions. Boca Raton: RC Press, Inc., 1990:21-28.
24. Jones TW, Thor H, Orrenius S. Cellular defense mechanisms against toxic substances. Arch Toxicol 1986;9(Suppl):259-271.
25. Uhlig S, Wendel A. Glutathione enhancement in various mouse organs and protection by glutathione isopropyl ester against liver injury. Biochem Pharmacol 1990;39:1877-1881.
26. Bergmeyer HU. Methods of Enzymatic Analysis. Volume 3. Weinheim: Verlag Chemie, 1983:1-605.
27. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969;27:502-522.